# The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.

> **NCT01426243** · PHASE3 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 71 (actual)

## Conditions studied

- HIV Infection
- Yellow Fever

## Interventions

- **BIOLOGICAL:** Yellow fever vaccination (STAMARIL)
- **BIOLOGICAL:** Yellow fever vaccination (STAMARIL)

## Key facts

- **NCT ID:** NCT01426243
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2017-02
- **Final completion:** 2017-12
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2019-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01426243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01426243, "The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01426243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*